Shares of iBio (NYSEMKT: IBIO) surged on Friday following positive analyst commentary. As of 1:35 p.m. EDT, the biologics manufacturer's stock was up more than 14%.
Cantor Fitzgerald analyst Kristen Kluska placed an overweight rating on iBio's stock after the market close on Thursday. She sees the biotech's shares rising roughly 80% from their current price near $1.66, to $3.
iBio's shareholders could enjoy handsome gains, according to an analyst at Cantor Fitzgerald. Image source: Getty Images.
Source Fool.com